Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 443INDUSTRY 174NIH 50NETWORK 29OTHER_GOV 11UNKNOWN 1INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 33Prostatic Neoplasms 26Neoplasms 22Colonic Neoplasms 12Lung Neoplasms 10Colonic Polyps 10Breast Neoplasms 10Rare Diseases 8Adenoma 6Pulmonary Disease, Chronic Obstructive 5Heart Failure 5Rectal Neoplasms 4Ovarian Neoplasms 4Pain 3Mental Disorders 3Death 3Adenomatous Polyps 3Uterine Cervical Neoplasms 2Urinary Incontinence 2Smoking Cessation 2Skin Neoplasms 2Sezary Syndrome 2Respiratory Aspiration 2Renal Insufficiency, Chronic 2Polycystic Ovary Syndrome 2Patient Preference 2Patient Compliance 2Obesity 2Neurologic Manifestations 2Neurofibromatosis 2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × FED × Urinary Bladder Neoplasms × Clear all
NCT04166240 2024-08-06

Measuring and Improving the Safety of Test Result Follow-Up

VA Office of Research and Development

Phase NA Completed
46 enrolled 3 charts
BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡